our knowledge, the first case of generalised NCSE precipitated by the use of piperacillin-tazobactam.
A 63-year-old woman without previous history of epilepsy was transferred to our hospital because of the occurrence of two generalised tonic-clonic seizures in the context of urinary sepsis. She had antecedents of Parkinson disease and personality disorder. During the last 10 days she had been diagnosed with urinary tract infection and had been taking fosfomycin without clinical improvement. Physical exanimation revealed a temperature of 38.2 8C. On neurologic examination she was alert and able to respond simple commands. No focal motor or sensory deficits were seen. Routine laboratory tests showed an increased peripheral white blood cell count (19 400 cells/mm 3 ) and pyuria but otherwise were unremarkable. A computed tomography (CT) scan of the brain was considered normal. Cerebrospinal fluid revealed also normal values. Treatment with intravenous piperacillin/ tazobactam (1500 mg/24 h) and phenytoin (300 mg/24 h) was started. Twenty-four hours later an EEG disclosed a discrete slowing of background activity suggestive of a mild diffuse encephalopathy. During the following 4 days, fever and urinary symptoms slightly improved; however, she developed a progressive worsening of her level of consciousness and mental state. On neurologic examination she was stuporous with poor spontaneous speech. At that moment, a second brain CT did not reveal significant changes. However, an urgent EEG showed intermittent generalised burst of polyspike-wave and spike-wave complexes at 1-2 Hz with frontal maximum in keeping with the diagnosis of generalised NCSE (Fig. 1 ). Piperacillin/tazobactam and phenytoin were discontinued, and intravenous treatment with ciprofloxacin, phenobarbital and clonazepam was initiated. Three days later, the patient had a slight recovery of her level of consciousness and a third EEG showed an excess of theta waves and frontal intermittent rhythmic delta activity without epileptiform discharges. During the next 15 days she experienced a gradual clinical improvement with some fluctuations on her mental status. Several EEGs revealed findings compatible with a diffuse encephalopathy but epileptiform activity never recurred. Finally, the patient was discharged with a normal baseline mental status. Piperacillin/tazobactam is a beta-lactam/beta-lactamase inhibitor combination with a broad spectrum of antibacterial activity against most Gram-positive and Gram-negative aerobic and anaerobic bacteria. Piperacillin/tazobactam has been associated with relatively low incidence of epileptic seizures. 
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Seizure j o u r n a l h o m e p a g e : w w w . e l s e v i e r . c o m / l o c a t e / y s e i z associated with episodes of situation-related generalised NCSE. 1, 4, 5 This epileptic condition affects often inpatients, generally adults or elderly people with moderate or severe subjacent pathology such as sepsis, infectious processes, renal failure, cancer or other metabolic derangements. It seems that many of these drugs share a similar pathophysiological mechanism since they can modify the intrinsic activity of diffuse inhibitory brain circuits mediated by gamma-aminobutyric acid, reducing the critical seizure threshold and precipitating the occurrence of generalised epileptiform discharges. As in our case both encephalopathy and NCSE may coexist above all in elderly patients with pluripathology. 6 Under these circumstances, it is difficult to determine exactly the contribution that seizure activity had in the development of the confusional picture. However, the clinical changes following the modification of the treatment support its role in patient's stupor. In summary, the diagnosis of generalised NCSE should be considered in all patients with unexpected changes in mental state on treatment with intravenous piperacillin/tazobactam. A high level of clinical suspicion, broad metabolic screening and, an emergent EEG are essential to obtain a prompt and accurate diagnosis.
